Bilastine/Montelukast
比拉斯汀/孟鲁司特钠
Report date: 2025/04/01 17:31:59
NME
Base Information
Drug NameBilastine/Montelukast
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes BilastineMontelukast
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynokem Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSynokem Pharmaceuticals Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A